INAB compared with MAIA: revenue, margins and what each company keeps, and the suppliers and customers both name

INABIN8BIO, Inc.

Mkt capRevenueRevenue

MAIAMAIA Biotechnology, Inc.

Mkt capRevenueRevenue

Compare

INABIN8BIO, Inc.

MAIAMAIA Biotechnology, Inc.

Price

Mkt cap

Revenue

Revenue flow

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

rebased to 0%

INAB, solidMAIA, dashed

INAB: latest quarter not drawable. MAIA: latest quarter not drawable.Method ›

INABIN8BIO, Inc.

0.94▼−4.09%· post 0.94

Mkt cap$8.9M

MAIAMAIA Biotechnology, Inc.

1.11▼−5.93%· post 1.11

ClosedOct 30 '26

Mkt cap$66.9M

Compare

ClosedOct 30 '26

INABIN8BIO, Inc.

MAIAMAIA Biotechnology, Inc.

0.94▼−4.09%post 0.94

Price

1.11▼−5.93%post 1.11

$8.9M

Mkt cap

$66.9M

INAB0.94▼−4.09%vsMAIA1.11▼−5.93%ClosedOct 30 '26

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: INAB, MAIA.

Role chip = supplier or customerSource: SEC EDGAR